Protective Effect of Gallic Acid in Experimental Model of Ketamine-induced Psychosis: Possible Behaviour, Biochemical, Neurochemical and Cellular Alterations

Overview

Journal Inflammopharmacology

Specialty Pharmacology

Date 2017 Jun 4

PMID 28577133

Citations 14

Authors

Monu Yadav

Deepak Kumar Jindal

Mamta Sachdeva Dhingra

Anil Kumar

Milind Parle

Sameer Dhingra

Affiliations

Soon will be listed here.

Abstract

Gallic acid has been reported to possess a number of psychopharmacological activities. These activities are attributed to the antioxidant potential due to the presence of phenolic moeity. The present study was carried out to investigate the protective effects of gallic acid in an experimental model of ketamine-induced psychosis in mice. Ketamine (50 mg/kg, i.p.) was used to induce stereotyped psychotic behavioural symptoms in mice. Behavioural studies (locomotor activity, stereotype behaviour, immobility duration and memory retention) were carried out to investigate the protective of gallic acid on ketamine-induced psychotic symptoms, followed by biochemical and neurochemical changes and cellular alterations in the brain. Chronic treatment with gallic acid for 15 consecutive days significantly attenuated stereotyped behavioural symptoms in mice. Biochemical estimations revealed that gallic acid reduced the lipid peroxidation and restored the total brain proteins. Furthermore, gallic acid remarkably reduced the dopamine levels, AChE activity and inflammatory surge (serum TNF-α), and increased the levels of GABA and increased glutathione in mice. The study revealed that gallic acid could ameliorate psychotic symptoms and biochemical changes in mice, indicating protective effects in psychosis.

Citing Articles

Medicinal plants and plant-based traditional medicine: Alternative treatments for depression and their potential mechanisms of action.

Remali J, Aizat W Heliyon. 2024; 10(20):e38986.

PMID: 39640650 PMC: 11620067. DOI: 10.1016/j.heliyon.2024.e38986.

Effects of piperine-haloperidol mixture on ketamine induced schizophrenia rats and metabolism-mediated inhibitory potency: in-vivo and in-vitro evaluation.

Pradeepa B, Vijayakumar T, Manikandan K 3 Biotech. 2024; 14(12):314.

PMID: 39619819 PMC: 11602896. DOI: 10.1007/s13205-024-04160-x.

Effects of extract on the cerebral oxidative and neuroinflammatory status in a mice model of schizophrenia.

Bahnamiri P, Moghaddam A, Ranjbar M, Nazifi E Biochem Biophys Rep. 2024; 37:101594.

PMID: 38371525 PMC: 10873873. DOI: 10.1016/j.bbrep.2023.101594.

Neuroprotective effects of alpha-pinene against behavioral deficits in ketamine-induced mice model of schizophrenia: Focusing on oxidative stress status.

Moghaddam A, Malekzadeh Estalkhi F, Khanjani Jelodar S, Ahmed Hasan T, Farhadi-Pahnedari S, Karimian M IBRO Neurosci Rep. 2024; 16:182-189.

PMID: 38318342 PMC: 10839590. DOI: 10.1016/j.ibneur.2023.12.012.

Suppresses PM-Induced Cognitive Dysfunction by Regulating Gut-Brain Axis via TLR-4/MyD88 Pathway.

Kim T, Kim J, Lee H, Go M, Joo S, Kim J Int J Mol Sci. 2023; 24(16).

PMID: 37629080 PMC: 10454605. DOI: 10.3390/ijms241612898.

References

Lull M, Block M . Microglial activation and chronic neurodegeneration. Neurotherapeutics. 2010; 7(4):354-65. PMC: 2951017. DOI: 10.1016/j.nurt.2010.05.014. View

Keefe R, Silva S, Perkins D, Lieberman J . The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull. 1999; 25(2):201-22. DOI: 10.1093/oxfordjournals.schbul.a033374. View

Dhingra M, Dhingra S, Kumria R, Chadha R, Singh T, Kumar A . Effect of trimethylgallic acid esters against chronic stress-induced anxiety-like behavior and oxidative stress in mice. Pharmacol Rep. 2014; 66(4):606-12. DOI: 10.1016/j.pharep.2014.01.004. View

Mosley R, Benner E, Kadiu I, Thomas M, Boska M, Hasan K . Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease. Clin Neurosci Res. 2007; 6(5):261-281. PMC: 1831679. DOI: 10.1016/j.cnr.2006.09.006. View

LOWE I, Robins E, EYERMAN G . The fluorometric measurement of glutamic decarboxylase and its distribution in brain. J Neurochem. 1958; 3(1):8-18. DOI: 10.1111/j.1471-4159.1958.tb12604.x. View

Halliwell B . Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging. 2001; 18(9):685-716. DOI: 10.2165/00002512-200118090-00004. View

WILLS E . THE EFFECT OF INORGANIC IRON ON THE THIOBARBITURIC ACID METHOD FOR THE DETERMINATION OF LIPID PEROXIDES. Biochim Biophys Acta. 1964; 84:475-7. DOI: 10.1016/0926-6542(64)90016-2. View

Dhingra D, Chhillar R, Gupta A . Antianxiety-like activity of gallic acid in unstressed and stressed mice: possible involvement of nitriergic system. Neurochem Res. 2011; 37(3):487-94. DOI: 10.1007/s11064-011-0635-7. View

Klinkenberg I, Sambeth A, Blokland A . Acetylcholine and attention. Behav Brain Res. 2010; 221(2):430-42. DOI: 10.1016/j.bbr.2010.11.033. View

10.

Reckziegel P, Dias V, Benvegnu D, Boufleur N, Barcelos R, Segat H . Antioxidant protection of gallic acid against toxicity induced by Pb in blood, liver and kidney of rats. Toxicol Rep. 2017; 3:351-356. PMC: 5615824. DOI: 10.1016/j.toxrep.2016.02.005. View

11.

Monji A, Kato T, Kanba S . Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci. 2009; 63(3):257-65. DOI: 10.1111/j.1440-1819.2009.01945.x. View

12.

Dhingra D, Bansal S . Antidepressant-like activity of plumbagin in unstressed and stressed mice. Pharmacol Rep. 2015; 67(5):1024-32. DOI: 10.1016/j.pharep.2015.03.001. View

13.

Kroes B, van den Berg A, Quarles van Ufford H, Van Dijk H, Labadie R . Anti-inflammatory activity of gallic acid. Planta Med. 1992; 58(6):499-504. DOI: 10.1055/s-2006-961535. View

14.

Faludi G, Dome P, Lazary J . Origins and perspectives of schizophrenia research. Neuropsychopharmacol Hung. 2011; 13(4):185-92. View

15.

Hoffman D, Donovan H . Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. Psychopharmacology (Berl). 1995; 120(2):128-33. DOI: 10.1007/BF02246184. View

16.

Choi W, Kim H, Xia Z . JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death. Toxicology. 2014; 328:75-81. PMC: 4308505. DOI: 10.1016/j.tox.2014.12.005. View

17.

Duncan G, Sheitman B, Lieberman J . An integrated view of pathophysiological models of schizophrenia. Brain Res Brain Res Rev. 1999; 29(2-3):250-64. DOI: 10.1016/s0165-0173(99)00002-8. View

18.

Chatterjee M, Verma P, Maurya R, Palit G . Evaluation of ethanol leaf extract of Ocimum sanctum in experimental models of anxiety and depression. Pharm Biol. 2011; 49(5):477-83. DOI: 10.3109/13880209.2010.523832. View

19.

Nagai T, Kitahara Y, Shiraki A, Hikita T, Taya S, Kaibuchi K . Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study. Neurosci Lett. 2010; 470(2):134-8. DOI: 10.1016/j.neulet.2009.12.071. View

20.

Koenig J, Elmer G, Shepard P, Lee P, Mayo C, Joy B . Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav Brain Res. 2004; 156(2):251-61. DOI: 10.1016/j.bbr.2004.05.030. View